A diaryl urea derivative, SMCl inhibits cell proliferation through the RAS/RAF/MEK/ERK pathway in hepatocellular carcinoma
IntroductionHepatocellular carcinoma (HCC) ranks among the three most prevalent cancer-related diseases in terms of incidence. Hence, exploring drugs for HCC therapy is of great significance. Compounds with a diaryl urea structure have been reported to exhibit a broad range of biological activities,...
Saved in:
| Main Authors: | Yue Fu, Weiyue Fang, Fuqiang Qiu, Juncai Lai, Yangjin Xu, Bin Chen, Yang Li, Xiaohui Zhu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1605515/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dayuan Yin alleviates symptoms of HCoV-229E-induced pneumonia and modulates the Ras/Raf1/MEK/ERK pathway
by: Rui Li, et al.
Published: (2024-11-01) -
ELABELA targets the MEK/ERK axis to enhance trophoblast invasion in early-onset preeclampsia
by: Lijing Wang, et al.
Published: (2025-08-01) -
Deltamethrin induces hippocampal neuronal MEK/ERK signaling pathway and apoptosis leading to neurobehavioral disorders in mice
by: WU Minjia, et al.
Published: (2025-02-01) -
Luteolin exhibits anti-breast cancer property through up-regulating miR-203
by: Guanglei Gao, et al.
Published: (2019-12-01) -
Micheliolide Alleviates Hepatic Fibrosis by Inhibiting Autophagy in Hepatic Stellate Cells via the TrxR1/2-Mediated ROS/MEK/ERK Pathway
by: Yi Liu, et al.
Published: (2025-02-01)